VEGFA and Global developmental delay: Ninety-six (51.1%), 16 (34.0%), and 30 (66.7%) infants receiving treatment with laser treatment, anti-VEGF therapy, and both laser and anti-VEGF, respectively, had cognitive delays, which was significantly different.